Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Increasing the Dose of Survivorship Care Planning in Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy

NCT03860961 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT03860961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03860961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Increasing the Dose of Survivorship Care Planning in Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy
Lead sponsor
NRG Oncology
Phase
Not applicable
Overall status
Completed
Start date
July 26, 2019
Completion date
September 4, 2025
Enrollment
550 (actual)
Sites
79

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma